First, FOXM1 gene expression is upregulated in ovarian cancer cells by both the metabolic enzyme aspartate N-acetyltransferase, which is overexpressed and associated with worse clinical outcomes in HGSC, and N-acetylaspartate, which is the most abundant onco-metabolite in HGSC tissues [315]. This evidence concerns the gene FOXM1 and ovarian cancer.